SELENOP and colorectal carcinoma: Our observation that rs2972994-SELENOP was associated with an increased risk of CRC and all colorectal neoplasia in the Irish cohort (p = 0.044) aligned with previous studies conducted by Peters et al. [35,36] on advanced CRA.